HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49658,
"recordsTotal": 49658,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=45000",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=44400",
"results": [
{
"registry_id": "NCT06191562",
"publication_url": "https://clinicaltrials.gov/study/NCT06191562",
"title": "Randomized Clinical Trial of Post-operative Outcomes Following Posterior Versus Anterior Tympanostomy Tube Placement",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "David Chi, MD",
"sponsor_slug": "david-chi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158854",
"publication_url": "https://clinicaltrials.gov/study/NCT06158854",
"title": "An Open-Label Phase 1/2 Study Evaluating the Safety and Efficacy of Etentamig (ABBV-383) in AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111781",
"publication_url": "https://clinicaltrials.gov/study/NCT06111781",
"title": "The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384807",
"publication_url": "https://clinicaltrials.gov/study/NCT06384807",
"title": "A Phase 1/2, First in Human, Dose Escalation and Dose Expansion Study of BHV-1510 (Previously PBI-410) as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biohaven Therapeutics Ltd.",
"sponsor_slug": "biohaven-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05681195",
"publication_url": "https://clinicaltrials.gov/study/NCT05681195",
"title": "Zanubrutinib With Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial With a Safety Lead-In",
"has_exemption": false,
"start_date": "2024-04-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504147",
"publication_url": "https://clinicaltrials.gov/study/NCT06504147",
"title": "A Phase 2, Randomised, Open Label, Multicentre Study of an Intraperitoneal α-emitting Radionuclide Therapy (Radspherin®) in Patients With Primary Advanced High-grade Serous or High-grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient and Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery",
"has_exemption": false,
"start_date": "2024-06-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oncoinvent Solutions AS",
"sponsor_slug": "oncoinvent-solutions-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06496178",
"publication_url": "https://clinicaltrials.gov/study/NCT06496178",
"title": "A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus B.V.",
"sponsor_slug": "merus-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06437574",
"publication_url": "https://clinicaltrials.gov/study/NCT06437574",
"title": "Lowering Cholesterol in Prostate Cancer to Target Rapamycin-Insensitive Companion Of MTOR (TORC2) in T-Cell Surface Glycoprotein CD8 Alpha Chain (CD8+) Lymphocytes",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06388083",
"publication_url": "https://clinicaltrials.gov/study/NCT06388083",
"title": "A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Belite Bio, Inc",
"sponsor_slug": "belite-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455787",
"publication_url": "https://clinicaltrials.gov/study/NCT06455787",
"title": "J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "JC Medical, Inc., an affiliate of Edwards Lifesciences LLC",
"sponsor_slug": "jc-medical-inc-an-affiliate-of-edwards-lifesciences-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06310031",
"publication_url": "https://clinicaltrials.gov/study/NCT06310031",
"title": "Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BrioHealth Solutions, Inc.",
"sponsor_slug": "briohealth-solutions-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336798",
"publication_url": "https://clinicaltrials.gov/study/NCT06336798",
"title": "Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568939",
"publication_url": "https://clinicaltrials.gov/study/NCT06568939",
"title": "A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092333",
"publication_url": "https://clinicaltrials.gov/study/NCT06092333",
"title": "A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699602",
"publication_url": "https://clinicaltrials.gov/study/NCT06699602",
"title": "A Pilot Phase II Study of Neoadjuvant Cemiplimab + Fianlimab in Patients With Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534060",
"publication_url": "https://clinicaltrials.gov/study/NCT06534060",
"title": "A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).",
"has_exemption": false,
"start_date": "2025-02-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "March Biosciences Inc",
"sponsor_slug": "march-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902311",
"publication_url": "https://clinicaltrials.gov/study/NCT06902311",
"title": "Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475781",
"publication_url": "https://clinicaltrials.gov/study/NCT06475781",
"title": "A Multinational Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Mirivadelgat, an Aldehyde Dehydrogenase 2 Activator, in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Foresee Pharmaceuticals Co., Ltd.",
"sponsor_slug": "foresee-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824792",
"publication_url": "https://clinicaltrials.gov/study/NCT06824792",
"title": "Real-world Study to Investigate Optimal Standard Treatment Selection for Solid Tumor Patients by Guided by Biologically-informed Multi-agent System",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "NING LI",
"sponsor_slug": "ning-li",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06522737",
"publication_url": "https://clinicaltrials.gov/study/NCT06522737",
"title": "A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SecuraBio",
"sponsor_slug": "securabio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730283",
"publication_url": "https://clinicaltrials.gov/study/NCT05730283",
"title": "Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Non-Tuberculous Mycobacterium Disease",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kevin Winthrop",
"sponsor_slug": "kevin-winthrop",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995677",
"publication_url": "https://clinicaltrials.gov/study/NCT06995677",
"title": "A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801639",
"publication_url": "https://clinicaltrials.gov/study/NCT06801639",
"title": "Advancing Alzheimer's Care: Home-based tDCS (Transcranial Direct Current Stimulator) for Affective Symptoms",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055594",
"publication_url": "https://clinicaltrials.gov/study/NCT07055594",
"title": "A Phase I/IIa Dose-escalation, Dose-optimization and Dose Expansion Study to Evaluate the Safety and Preliminary Efficacy of Tri-specific Antibody (SOA101) in Subjects With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Shine-On Biomedical Co., Ltd.",
"sponsor_slug": "shine-on-biomedical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145918",
"publication_url": "https://clinicaltrials.gov/study/NCT07145918",
"title": "An Adaptive Two-part Randomized, Double Blind, Placebo-controlled Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Emraclidine in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029581",
"publication_url": "https://clinicaltrials.gov/study/NCT07029581",
"title": "A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925321",
"publication_url": "https://clinicaltrials.gov/study/NCT06925321",
"title": "An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Basilea Pharmaceutica",
"sponsor_slug": "basilea-pharmaceutica",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06955728",
"publication_url": "https://clinicaltrials.gov/study/NCT06955728",
"title": "A Phase-IIIb Individually Randomized, Placebo-controlled Trial on Safety of RSVA/B-preF Vaccine in Pregnant Women and Efficacy Against Severe RSV-associated Lower Respiratory Tract Infection in Infants",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Witwatersrand, South Africa",
"sponsor_slug": "university-of-witwatersrand-south-africa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521476",
"publication_url": "https://clinicaltrials.gov/study/NCT06521476",
"title": "Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanjay R Patel",
"sponsor_slug": "sanjay-r-patel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800963",
"publication_url": "https://clinicaltrials.gov/study/NCT06800963",
"title": "ResQ133A-NMIBC: Phase 1/2 Clinical Trial of Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221851",
"publication_url": "https://clinicaltrials.gov/study/NCT07221851",
"title": "A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma A/S",
"sponsor_slug": "ascendis-pharma-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284875",
"publication_url": "https://clinicaltrials.gov/study/NCT07284875",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288320",
"publication_url": "https://clinicaltrials.gov/study/NCT07288320",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder Who Are Currently Experiencing a Manic Episode or Manic Episode With Mixed Features, With or Without Psychotic Symptoms, and Warrant Inpatient Hospitalization",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201519",
"publication_url": "https://clinicaltrials.gov/study/NCT07201519",
"title": "Phase IIa Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael J Cavnar, MD",
"sponsor_slug": "michael-j-cavnar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07494305",
"publication_url": "https://clinicaltrials.gov/study/NCT07494305",
"title": "A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With Major Depressive Episodes Associated With Bipolar I Disorder",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "LB Pharmaceuticals Inc.",
"sponsor_slug": "lb-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07412756",
"publication_url": "https://clinicaltrials.gov/study/NCT07412756",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Major Depressive Disorder (RENEW-MDD 1)",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192731",
"publication_url": "https://clinicaltrials.gov/study/NCT07192731",
"title": "Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191548",
"publication_url": "https://clinicaltrials.gov/study/NCT07191548",
"title": "Treatment of LIVER METastases From Colorectal Cancer by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study.",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07404111",
"publication_url": "https://clinicaltrials.gov/study/NCT07404111",
"title": "An Adaptive Phase 1/2 MulticenteR Study Evaluating the Safety, Tolerability, Pharmacokinetics and EfficaCy of VV-14305 Delivered Via PeribuLbAr Injection in Patients With Moderate to Severe Thyroid Eye Disease (the RECLAIM Study)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kriya Therapeutics, Inc.",
"sponsor_slug": "kriya-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07434635",
"publication_url": "https://clinicaltrials.gov/study/NCT07434635",
"title": "APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07355231",
"publication_url": "https://clinicaltrials.gov/study/NCT07355231",
"title": "Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Xemed LLC",
"sponsor_slug": "xemed-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07492160",
"publication_url": "https://clinicaltrials.gov/study/NCT07492160",
"title": "Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms After 12-18 Week Abortion or Pregnancy Loss: A Pilot and Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Maimonides Medical Center",
"sponsor_slug": "maimonides-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07382674",
"publication_url": "https://clinicaltrials.gov/study/NCT07382674",
"title": "Zesty Exercise System for Therapeutic Engagement",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318584",
"publication_url": "https://clinicaltrials.gov/study/NCT07318584",
"title": "Cefotetan Therapy for Escherichia Coli Bacteremia and Genitourinary Infections: a Prospective Phase II Pilot Study",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416604",
"publication_url": "https://clinicaltrials.gov/study/NCT07416604",
"title": "A Multicenter, Randomized, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of NXT007 Prophylaxis Versus Emicizumab Prophylaxis in People With Hemophilia A",
"has_exemption": false,
"start_date": "2026-04-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07429110",
"publication_url": "https://clinicaltrials.gov/study/NCT07429110",
"title": "ColoSeal™ ICD System Anastomotic Protection Pivotal Study",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Averto Medical, Inc.",
"sponsor_slug": "averto-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285005",
"publication_url": "https://clinicaltrials.gov/study/NCT07285005",
"title": "A Phase 3, Randomized, Parallel, Multicenter, Double-blind, Placebo-controlled Study to Investigate Efficacy and Safety of KP 001 in Patients Aged ≥2 Years With Common Venous Malformations, Common Lymphatic Malformations, or KTS/CLOVES Syndrome",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kaken Pharmaceutical",
"sponsor_slug": "kaken-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428616",
"publication_url": "https://clinicaltrials.gov/study/NCT07428616",
"title": "A Phase 2, Single-Arm, Multicenter, Open-Label Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226063",
"publication_url": "https://clinicaltrials.gov/study/NCT07226063",
"title": "A Phase II Study of Maintenance Zanzalintinib and Durvalumab in Patients With Advanced Hepatocellular Cancer After Induction Tremelimumab Plus Durvalumab",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amit Mahipal",
"sponsor_slug": "amit-mahipal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286331",
"publication_url": "https://clinicaltrials.gov/study/NCT07286331",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy",
"has_exemption": false,
"start_date": "2026-06-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07693452",
"publication_url": "https://clinicaltrials.gov/study/NCT07693452",
"title": "Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07488988",
"publication_url": "https://clinicaltrials.gov/study/NCT07488988",
"title": "SCARFREE-001: A Phase 2 Dose-Finding and Proof-of-Concept Study of Intradermal Verteporfin for Scar Prevention in Open and Closed Surgical Wounds",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Odense University Hospital",
"sponsor_slug": "odense-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07534709",
"publication_url": "https://clinicaltrials.gov/study/NCT07534709",
"title": "Suzetrigine Versus Placebo for Opioid-Free Recovery After Cesarean Delivery: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07621237",
"publication_url": "https://clinicaltrials.gov/study/NCT07621237",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tonix Pharmaceuticals, Inc.",
"sponsor_slug": "tonix-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06419205",
"publication_url": "https://clinicaltrials.gov/study/NCT06419205",
"title": "A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Clinical Activity of ADX-097 Administered Subcutaneously in Male and Female Participants Aged 16 Years or Older With Immunoglobulin A Nephropathy (IgAN), Lupus Nephritis (LN), or Complement Component 3 Glomerulopathy (C3G)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Akebia Therapeutics",
"sponsor_slug": "akebia-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07465718",
"publication_url": "https://clinicaltrials.gov/study/NCT07465718",
"title": "Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Orphalan",
"sponsor_slug": "orphalan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07673614",
"publication_url": "https://clinicaltrials.gov/study/NCT07673614",
"title": "Improving Sensorimotor Function in CIPN: A Randomized, Sham Controlled, Double Blinded, Crossover Mechanistic Trial of Transcranial Direct Current to the Sensorimotor Cortex",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907485",
"publication_url": "https://clinicaltrials.gov/study/NCT06907485",
"title": "A Multicenter Study to Assess the Feasibility of Gleolan (ALA / Aminolevulinic Acid HCl) in Pediatric Brain Tumor Patients After Delayed Administration",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Costas Hadjipanayis",
"sponsor_slug": "costas-hadjipanayis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428681",
"publication_url": "https://clinicaltrials.gov/study/NCT07428681",
"title": "Preventive Administration of Lorazepam in Critically Ill Patients With High Anttila-Index to Reduce the Incidence of Intensive Care Delirium: a Single-centre, Randomized, Controlled Clinical Trial - the Basel LOC2DEL-Trial",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Basel, Switzerland",
"sponsor_slug": "university-hospital-basel-switzerland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114679",
"publication_url": "https://clinicaltrials.gov/study/NCT07114679",
"title": "Molecular Breast Imaging (MBI)-Guided Biopsy Pilot SBIR",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Smart Breast Corp.",
"sponsor_slug": "smart-breast-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02991469",
"publication_url": "https://clinicaltrials.gov/study/NCT02991469",
"title": "An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, With Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase",
"has_exemption": false,
"start_date": "2018-08-09",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404088",
"publication_url": "https://clinicaltrials.gov/study/NCT04404088",
"title": "A Phase II Study of Acalabrutinib, Lenalidomide, and Rituximab (aR2) in Patients With Previously Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-07-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04560322",
"publication_url": "https://clinicaltrials.gov/study/NCT04560322",
"title": "A Phase 2 Study of MRD Adapted Therapy With Venetoclax-obinutuzumab in Patients With High or Intermediate BALL Risk Relapsed or Refractory CLL, With Addition of Acalabrutinib in Patients Who Fail to Achieve MRD Eradication",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747912",
"publication_url": "https://clinicaltrials.gov/study/NCT04747912",
"title": "A Phase II Study of a Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia (ALL) Incorporating Inotuzumab Ozogamicin (InO)",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04394858",
"publication_url": "https://clinicaltrials.gov/study/NCT04394858",
"title": "A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma",
"has_exemption": false,
"start_date": "2021-03-17",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871139",
"publication_url": "https://clinicaltrials.gov/study/NCT04871139",
"title": "Contrast-Enhanced Mammography (CEM) for the Evaluation and Targeted Biopsy of Suspicious Mammographic Architectural Distortions",
"has_exemption": false,
"start_date": "2021-04-08",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04941274",
"publication_url": "https://clinicaltrials.gov/study/NCT04941274",
"title": "A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05488431",
"publication_url": "https://clinicaltrials.gov/study/NCT05488431",
"title": "Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Priscilla Hsue, MD",
"sponsor_slug": "priscilla-hsue-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05727904",
"publication_url": "https://clinicaltrials.gov/study/NCT05727904",
"title": "A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel (LN-144, Autologous Tumor Infiltrating Lymphocytes [TIL]) Regimen in Combination With Pembrolizumab Compared With Pembrolizumab Monotherapy in Participants With Untreated, Unresectable or Metastatic Melanoma",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05706025",
"publication_url": "https://clinicaltrials.gov/study/NCT05706025",
"title": "Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05758701",
"publication_url": "https://clinicaltrials.gov/study/NCT05758701",
"title": "Dual Energy CT Decreased IV Contrast Dose Imaging for TAVR",
"has_exemption": false,
"start_date": "2023-09-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097468",
"publication_url": "https://clinicaltrials.gov/study/NCT06097468",
"title": "A Phase I/IIa, Single-Arm, Dose-Confirmation and Dose-Expansion Study Evaluating Changes in the Oral Microbiome of Patients With Oral Cavity Squamous Cell Carcinoma (OSCC) After Short-Term Ingestion of Nisin, a Naturally Occurring Food Preservative",
"has_exemption": false,
"start_date": "2024-02-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06633913",
"publication_url": "https://clinicaltrials.gov/study/NCT06633913",
"title": "Neural Effects of Transcranial Magnetic Stimulation Using Concurrent Functional Magnetic Resonance Imaging",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jing Jiang",
"sponsor_slug": "jing-jiang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06275776",
"publication_url": "https://clinicaltrials.gov/study/NCT06275776",
"title": "The Effect of Suturing Techniques on Aberrant Wound Recovery After Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reinier Haga Orthopedisch Centrum",
"sponsor_slug": "reinier-haga-orthopedisch-centrum",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157099",
"publication_url": "https://clinicaltrials.gov/study/NCT06157099",
"title": "A Decentralized Phase II Randomized Controlled Trial of Atorvastatin in Resected High-Risk Melanoma",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06398106",
"publication_url": "https://clinicaltrials.gov/study/NCT06398106",
"title": "Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06675344",
"publication_url": "https://clinicaltrials.gov/study/NCT06675344",
"title": "A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Robyn T. Domsic, MD, MPH",
"sponsor_slug": "robyn-t-domsic-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06563596",
"publication_url": "https://clinicaltrials.gov/study/NCT06563596",
"title": "A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592833",
"publication_url": "https://clinicaltrials.gov/study/NCT06592833",
"title": "Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216222",
"publication_url": "https://clinicaltrials.gov/study/NCT07216222",
"title": "Intracranial Recording and Stimulation of the Human Hippocampal-Amygdala Circuit During Virtual Reality Fear Conditioning",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580054",
"publication_url": "https://clinicaltrials.gov/study/NCT06580054",
"title": "Pembrolizumab for Orbital and Periocular Cutaneous Squamous Cell Carcinoma (cSCC)",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849713",
"publication_url": "https://clinicaltrials.gov/study/NCT06849713",
"title": "A Multicenter Phase 2 Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax (BOSon) or Catadegbrutinib (BGB-16673), Obinutuzumab, and Sonrotoclax (DOSon) in Treatment-Naïve Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959511",
"publication_url": "https://clinicaltrials.gov/study/NCT06959511",
"title": "ZAnzalintinib Neoadjuvant EValuation in Thyroid Oncology (ZANEVO)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05535361",
"publication_url": "https://clinicaltrials.gov/study/NCT05535361",
"title": "A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eclipse Regenesis, Inc.",
"sponsor_slug": "eclipse-regenesis-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07123454",
"publication_url": "https://clinicaltrials.gov/study/NCT07123454",
"title": "A Modular Phase I/II Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Efficacy of AZD4512 Monotherapy or in Combination With Other Anticancer Agent(s), in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) (Lumi-NHL)",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934239",
"publication_url": "https://clinicaltrials.gov/study/NCT06934239",
"title": "A Randomized Controlled Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06971731",
"publication_url": "https://clinicaltrials.gov/study/NCT06971731",
"title": "A Phase 3, Double-Blind, Randomized, Two-Period, Multicenter, Placebo-Controlled, Efficacy and Safety Study of JNT-517 for the Treatment of Participants With Phenylketonuria",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07025330",
"publication_url": "https://clinicaltrials.gov/study/NCT07025330",
"title": "A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377215",
"publication_url": "https://clinicaltrials.gov/study/NCT06377215",
"title": "Understanding Aided Speech Perception in Noise: Behavioral and Electrophysiological Measures",
"has_exemption": false,
"start_date": "2025-11-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of South Florida",
"sponsor_slug": "university-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265843",
"publication_url": "https://clinicaltrials.gov/study/NCT07265843",
"title": "Fibrinogen in Liver Transplant Subjects (FITS)",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Trauma Hemostatis and Oxygenation Research (THOR) Network",
"sponsor_slug": "trauma-hemostatis-and-oxygenation-research-thor-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07270276",
"publication_url": "https://clinicaltrials.gov/study/NCT07270276",
"title": "The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318688",
"publication_url": "https://clinicaltrials.gov/study/NCT07318688",
"title": "A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-Associated Pain Over a 24-Week Treatment Period and a 28-Week Extension",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hope Medicine (Nanjing) Co., Ltd",
"sponsor_slug": "hope-medicine-nanjing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369310",
"publication_url": "https://clinicaltrials.gov/study/NCT07369310",
"title": "Randomized Trial on DBS Programming Based on Biomarkers vs. Standard Monopolar Review",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau",
"sponsor_slug": "fundacio-institut-de-recerca-de-lhospital-de-la-santa-creu-i-sant-pau",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07403058",
"publication_url": "https://clinicaltrials.gov/study/NCT07403058",
"title": "Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Reduced Ejection Fraction: Randomized Controlled Feasibility Trial",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Axon Therapies, Inc.",
"sponsor_slug": "axon-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430917",
"publication_url": "https://clinicaltrials.gov/study/NCT07430917",
"title": "A Phase II, Randomized, Placebo-Controlled, Double-Blind, Adaptive Study to Assess the Safety and Efficacy of Intravenous J147 Combined With Endovascular Therapy in Patients With Acute Ischemic Stroke",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Abrexa Pharmaceuticals, Inc.",
"sponsor_slug": "abrexa-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07394608",
"publication_url": "https://clinicaltrials.gov/study/NCT07394608",
"title": "Use of Paired Non-Invasive Vagus Nerve Stimulation in Rehabilitation of Adolescents With Cerebral Palsy: An Open Label Safety Feasibility Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07251491",
"publication_url": "https://clinicaltrials.gov/study/NCT07251491",
"title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "James J. Peters Veterans Affairs Medical Center",
"sponsor_slug": "james-j-peters-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07405190",
"publication_url": "https://clinicaltrials.gov/study/NCT07405190",
"title": "A Phase II Study of Ivonescimab as Monotherapy or in Combination With Platinum/Pemetrexed Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring Actionable Genomic Alterations (AGAs)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07410598",
"publication_url": "https://clinicaltrials.gov/study/NCT07410598",
"title": "Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07377526",
"publication_url": "https://clinicaltrials.gov/study/NCT07377526",
"title": "Phase 1/2 Study Of IL15-Transduced, TGFBR2 KO, TROP2 CAR- Engineered Cord Blood-Derived NK Cells Administered Intraperitoneally And Intravenously In Combination With Oral Belzutifan For The Management Of Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-05-26",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215858",
"publication_url": "https://clinicaltrials.gov/study/NCT07215858",
"title": "Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of the Safety and Efficacy of BPL-1357 Against H1N1 Influenza Virus Challenge",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07676331",
"publication_url": "https://clinicaltrials.gov/study/NCT07676331",
"title": "Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07685743",
"publication_url": "https://clinicaltrials.gov/study/NCT07685743",
"title": "Extended Post-operative Oral TXA vs.Standard Perioperative TXA in Primary TJA: A Randomized, Double-Blind, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03571945",
"publication_url": "https://clinicaltrials.gov/study/NCT03571945",
"title": "Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sir Ganga Ram Hospital",
"sponsor_slug": "sir-ganga-ram-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05732402",
"publication_url": "https://clinicaltrials.gov/study/NCT05732402",
"title": "An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3)",
"has_exemption": false,
"start_date": "2023-03-15",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpine Immune Sciences, Inc.",
"sponsor_slug": "alpine-immune-sciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06676579",
"publication_url": "https://clinicaltrials.gov/study/NCT06676579",
"title": "A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07586202",
"publication_url": "https://clinicaltrials.gov/study/NCT07586202",
"title": "A Phase 2 Study Evaluating the Safety and Efficacy of Neoadjuvant Amivantamab in Combination With Lazertinib or Chemotherapy in Resectable EGFR-Mutated Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-17",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05402332",
"publication_url": "https://clinicaltrials.gov/study/NCT05402332",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva Morava-Kozicz",
"sponsor_slug": "eva-morava-kozicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05834296",
"publication_url": "https://clinicaltrials.gov/study/NCT05834296",
"title": "Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 1/2a Study to Assess Safety, Tolerability & Efficacy of Autologous Beta-Amyloid Mutant Peptide-pulsed Dendritic Cells in Subjects With Mild-to-Moderate Alzheimer's Dementia",
"has_exemption": false,
"start_date": "2023-07-05",
"completion_date": "2028-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Alzamend Neuro, Inc.",
"sponsor_slug": "alzamend-neuro-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447063",
"publication_url": "https://clinicaltrials.gov/study/NCT07447063",
"title": "The Impact of Dietary Salt on the Severity of Eczema",
"has_exemption": false,
"start_date": "2026-06-22",
"completion_date": "2028-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332091",
"publication_url": "https://clinicaltrials.gov/study/NCT07332091",
"title": "A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study of the Efficacy and Safety of Vamifeport in Adult Subjects With HFE-related Hereditary Hemochromatosis (FERROCLEAR Study)",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2028-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03471650",
"publication_url": "https://clinicaltrials.gov/study/NCT03471650",
"title": "A Phase II Study to Evaluate the Performance of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer in Men With an Elevated PSA",
"has_exemption": false,
"start_date": "2018-03-29",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05142696",
"publication_url": "https://clinicaltrials.gov/study/NCT05142696",
"title": "A Phase Ib/II Dose Finding Study Assessing Safety and Efficacy of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide, and Atezolizumab in Induction and With Atezolizumab in Maintenance Phase",
"has_exemption": false,
"start_date": "2022-07-13",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284420",
"publication_url": "https://clinicaltrials.gov/study/NCT07284420",
"title": "An ISA to Master Protocol ARGX-999-2-MG-2000 for an Exploratory, Phase 2a, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart IV as Add-On Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852963",
"publication_url": "https://clinicaltrials.gov/study/NCT06852963",
"title": "A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 (30 μg and 75 μg) Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 in the PLATYPUS Study (Protocol # VP001-101) or WALLABY Study (Protocol # VP001-102) for a Minimum of 8 Weeks",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "PYC Therapeutics",
"sponsor_slug": "pyc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928662",
"publication_url": "https://clinicaltrials.gov/study/NCT06928662",
"title": "Sequential Decitabine in Combination With FLAG-Ida Followed Immediately by Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (DEC-FLAG-Ida/RIC) for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1/2 Study",
"has_exemption": false,
"start_date": "2025-09-23",
"completion_date": "2028-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04276870",
"publication_url": "https://clinicaltrials.gov/study/NCT04276870",
"title": "CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)",
"has_exemption": false,
"start_date": "2020-03-12",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephan Grupp MD PhD",
"sponsor_slug": "stephan-grupp-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144280",
"publication_url": "https://clinicaltrials.gov/study/NCT07144280",
"title": "PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335588",
"publication_url": "https://clinicaltrials.gov/study/NCT07335588",
"title": "A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream in Adult Participants With Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "LEO Pharma",
"sponsor_slug": "leo-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07615686",
"publication_url": "https://clinicaltrials.gov/study/NCT07615686",
"title": "Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Bailey Petersen",
"sponsor_slug": "bailey-petersen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07689188",
"publication_url": "https://clinicaltrials.gov/study/NCT07689188",
"title": "An Open-Label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-08-10",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Harrison Dermatology",
"sponsor_slug": "harrison-dermatology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926868",
"publication_url": "https://clinicaltrials.gov/study/NCT06926868",
"title": "IZABRIGHT-Breast01: A Randomized, Open-label, Inferentially Seamless Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment",
"has_exemption": false,
"start_date": "2025-09-11",
"completion_date": "2028-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453044",
"publication_url": "https://clinicaltrials.gov/study/NCT06453044",
"title": "A Phase 2 Study of Mosunetuzumab With Polatuzumab Vedotin in Patients With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01295645",
"publication_url": "https://clinicaltrials.gov/study/NCT01295645",
"title": "A Phase II Randomized Study of Cidofovir Versus Best Supportive Care for Polyomavirus Hominis Type I (BK) Virus Related Hemorrhagic Cystitis After Stem Cell Transplant",
"has_exemption": false,
"start_date": "2011-03-17",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06245109",
"publication_url": "https://clinicaltrials.gov/study/NCT06245109",
"title": "Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2024-02-26",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616766",
"publication_url": "https://clinicaltrials.gov/study/NCT06616766",
"title": "A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, PK and Anti-tumor Activity of YH42946 in Patients With Locally Advanced or Metastatic Solid Tumors With HER2 Aberration and EGFR Exon 20 Insertion",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Yuhan Corporation",
"sponsor_slug": "yuhan-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06605105",
"publication_url": "https://clinicaltrials.gov/study/NCT06605105",
"title": "A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Cybin IRL Limited",
"sponsor_slug": "cybin-irl-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747611",
"publication_url": "https://clinicaltrials.gov/study/NCT06747611",
"title": "Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722235",
"publication_url": "https://clinicaltrials.gov/study/NCT06722235",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants With Chronic Primary Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07487831",
"publication_url": "https://clinicaltrials.gov/study/NCT07487831",
"title": "The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease",
"has_exemption": false,
"start_date": "2026-06-22",
"completion_date": "2028-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07476287",
"publication_url": "https://clinicaltrials.gov/study/NCT07476287",
"title": "A PHASE 2 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED TRANSFORMED SMALL CELL LUNG CANCER",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2028-03-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305247",
"publication_url": "https://clinicaltrials.gov/study/NCT06305247",
"title": "An Open-label, Phase I/IIa First-in-human, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Antitumour Activity of ERK1/2 Inhibitor IPN01194 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2028-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05025800",
"publication_url": "https://clinicaltrials.gov/study/NCT05025800",
"title": "A Phase I/II Open Label, Single Center, Study of the Combination of ALX148, Rituximab and Lenalidomide in Patients With Indolent and Aggressive B-Cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2021-10-13",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05160922",
"publication_url": "https://clinicaltrials.gov/study/NCT05160922",
"title": "CRIZOTINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED CRIZOTINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2021-12-27",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04804553",
"publication_url": "https://clinicaltrials.gov/study/NCT04804553",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)",
"has_exemption": false,
"start_date": "2022-03-17",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350097",
"publication_url": "https://clinicaltrials.gov/study/NCT06350097",
"title": "A Phase III, Open-label, Randomised Study of Osimertinib With or Without Datopotamab Deruxtecan (Dato-DXd), as First-line Treatment in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597019",
"publication_url": "https://clinicaltrials.gov/study/NCT06597019",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children (6 to Less Than 12 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL- Cholesterol",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03412877",
"publication_url": "https://clinicaltrials.gov/study/NCT03412877",
"title": "A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in Patients With Metastatic Cancer",
"has_exemption": false,
"start_date": "2018-09-06",
"completion_date": "2028-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597006",
"publication_url": "https://clinicaltrials.gov/study/NCT06597006",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949684",
"publication_url": "https://clinicaltrials.gov/study/NCT05949684",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) vs Epoetin Alfa for the Treatment of Anemia Due to Revised International Prognostic Scoring System (IPSS-R) Very Low, Low, or Intermediate-Risk Myelodysplastic Syndrome (MDS) in Erythropoiesis-Stimulating Agent (ESA)-Naive Participants Who Are Non-Transfusion Dependent (NTD): The \"ELEMENT-MDS\" Trial",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06141486",
"publication_url": "https://clinicaltrials.gov/study/NCT06141486",
"title": "A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-12-27",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221188",
"publication_url": "https://clinicaltrials.gov/study/NCT07221188",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332455",
"publication_url": "https://clinicaltrials.gov/study/NCT07332455",
"title": "A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Dose Optimization Study of GSK5471713 in Adult Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213973",
"publication_url": "https://clinicaltrials.gov/study/NCT07213973",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2028-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05530421",
"publication_url": "https://clinicaltrials.gov/study/NCT05530421",
"title": "Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)",
"has_exemption": false,
"start_date": "2023-03-26",
"completion_date": "2028-03-26",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284901",
"publication_url": "https://clinicaltrials.gov/study/NCT07284901",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2028-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616910",
"publication_url": "https://clinicaltrials.gov/study/NCT05616910",
"title": "Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06939348",
"publication_url": "https://clinicaltrials.gov/study/NCT06939348",
"title": "Safety and Efficacy of Thalamic Focused Ultrasound Stimulation (tFUS) for Promoting Recovery After Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-26",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136181",
"publication_url": "https://clinicaltrials.gov/study/NCT07136181",
"title": "A Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novelwise Pharmaceutical Corporation",
"sponsor_slug": "novelwise-pharmaceutical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290140",
"publication_url": "https://clinicaltrials.gov/study/NCT07290140",
"title": "A Randomized, Controlled, Blinded, Multi-Center Trial to Assess the Safety and Efficacy of Paclitaxel-Coated Sinus Balloon as an Adjunct to Endoscopic Sinus Surgery in Adult Chronic Rhinosinusitis Subjects",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Airiver Medical, Inc.",
"sponsor_slug": "airiver-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07508787",
"publication_url": "https://clinicaltrials.gov/study/NCT07508787",
"title": "Phase 2b, Randomized, Multicenter, Double-Blind, Dose-Finding, Active-Controlled Study of Siplizumab (TCD601) Compared to Rabbit Anti-Thymocyte Globulin in Renal Transplant Recipients Requiring Induction Therapy and Receiving Standard of Care Immunosuppression With Tacrolimus, Mycophenolic Acid and Corticosteroids",
"has_exemption": false,
"start_date": "2026-06-29",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Nefro Avillion Clinical Development, LLC",
"sponsor_slug": "nefro-avillion-clinical-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221227",
"publication_url": "https://clinicaltrials.gov/study/NCT07221227",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2028-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07298473",
"publication_url": "https://clinicaltrials.gov/study/NCT07298473",
"title": "Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2028-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiac Ablation Solutions",
"sponsor_slug": "medtronic-cardiac-ablation-solutions",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03950609",
"publication_url": "https://clinicaltrials.gov/study/NCT03950609",
"title": "A Phase II Study of Lenvatinib in Combination With Everolimus in Patients With Advanced Carcinoid Tumors",
"has_exemption": false,
"start_date": "2019-07-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05027633",
"publication_url": "https://clinicaltrials.gov/study/NCT05027633",
"title": "Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05316155",
"publication_url": "https://clinicaltrials.gov/study/NCT05316155",
"title": "Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants With Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2022-04-11",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05811364",
"publication_url": "https://clinicaltrials.gov/study/NCT05811364",
"title": "The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease",
"has_exemption": false,
"start_date": "2023-10-17",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091865",
"publication_url": "https://clinicaltrials.gov/study/NCT06091865",
"title": "A Phase 3, Open Label, Randomized Study Comparing the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 × Anti-CD3 Bispecific Antibody, in Combination With CHOP (ODRO-CHOP) Versus Rituximab in Combination With CHOP (R-CHOP) in Previously Untreated Participants With Diffuse Large B-cell Lymphoma (DLBCL) (OLYMPIA-3)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06213324",
"publication_url": "https://clinicaltrials.gov/study/NCT06213324",
"title": "Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644768",
"publication_url": "https://clinicaltrials.gov/study/NCT06644768",
"title": "A Multicenter, Randomized, Open-Label, Phase 1b/2 Trial Of Valemetostat Tosylate Plus Pembrolizumab Vs Pembrolizumab Alone in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Tumor Proportion Score ≥50% Without Actionable Genomic Alterations",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06877650",
"publication_url": "https://clinicaltrials.gov/study/NCT06877650",
"title": "A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of JMT108 Injection in Participants With Advanced Malignant Tumors.",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai JMT-Bio Inc.",
"sponsor_slug": "shanghai-jmt-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06905054",
"publication_url": "https://clinicaltrials.gov/study/NCT06905054",
"title": "Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166757",
"publication_url": "https://clinicaltrials.gov/study/NCT07166757",
"title": "A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Human Allogeneic Induced Pluripotent Stem Cell-derived Dopaminergic Neural Progenitor Cell Injection in the Treatment of Early-onset Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.",
"sponsor_slug": "xellsmart-bio-pharmaceutical-suzhou-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169175",
"publication_url": "https://clinicaltrials.gov/study/NCT07169175",
"title": "A Multicenter, Open-label, Single-arm, Dose Escalation and Expansion, Phase I/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SNUG01 in Adult Subjects With Amyotrophic Lateral Sclerosis (ALS)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SineuGene Therapeutics Co., Ltd.",
"sponsor_slug": "sineugene-therapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115329",
"publication_url": "https://clinicaltrials.gov/study/NCT07115329",
"title": "Phase 2, Multicenter, Randomized, Double-Blind Evaluation of the Efficacy and Safety of Oral GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Syndeio Biosciences, Inc",
"sponsor_slug": "syndeio-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07350174",
"publication_url": "https://clinicaltrials.gov/study/NCT07350174",
"title": "A Multicenter, Open-label, Randomized, Active-controlled, Phase 2a Study to Evaluate the Pharmacokinetics and Safety of Alpibectir/Ethionamide in Combination With the Standard Regimen in Patients With Tuberculosis Meningitis.",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioVersys AG",
"sponsor_slug": "bioversys-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07594158",
"publication_url": "https://clinicaltrials.gov/study/NCT07594158",
"title": "A Multicenter, Open-label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ONO-2017 in Japanese Patients With Partial Onset Seizures Aged 2 to Under 18 Years.",
"has_exemption": false,
"start_date": "2026-05-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07642284",
"publication_url": "https://clinicaltrials.gov/study/NCT07642284",
"title": "A Prospective, Parallel-group, Randomized Clinical Investigation Evaluating Performance and Safety of the AH Plus Jet® Sealing Materials Used in Single-cone Technique for Single Visit Endodontic Treatment. A 2-year Follow-up Study",
"has_exemption": false,
"start_date": "2026-05-30",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dentsply Sirona Implants and Consumables",
"sponsor_slug": "dentsply-sirona-implants-and-consumables",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07403968",
"publication_url": "https://clinicaltrials.gov/study/NCT07403968",
"title": "An Open-Label, Single-Arm, Phase 2a Trial to Evaluate the Safety, Tolerability, PK, and Mechanism of Action of Zasocitinib (TAK-279) in Participants With Active Crohn's Disease",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07718737",
"publication_url": "https://clinicaltrials.gov/study/NCT07718737",
"title": "Open-Label, Global, Multicenter, Randomized, Phase 2/3 Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2026-08-28",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Multitude Therapeutics Inc.",
"sponsor_slug": "multitude-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03514329",
"publication_url": "https://clinicaltrials.gov/study/NCT03514329",
"title": "Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Definitive Treatment Study",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Uptake Medical Technology, Inc.",
"sponsor_slug": "uptake-medical-technology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03414502",
"publication_url": "https://clinicaltrials.gov/study/NCT03414502",
"title": "Treatment of Rheumatoid Arthritis With Disease-modifying Antirheumatic Drugs (DMARDs): Predictors of Response",
"has_exemption": false,
"start_date": "2007-12-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02174549",
"publication_url": "https://clinicaltrials.gov/study/NCT02174549",
"title": "Phase I Dose-Escalating Study of Combining Intravenous Tirapazamine and Transarterial Embolization (TAE) in Liver Cancer",
"has_exemption": false,
"start_date": "2014-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Teclison Ltd.",
"sponsor_slug": "teclison-ltd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02324387",
"publication_url": "https://clinicaltrials.gov/study/NCT02324387",
"title": "Assessment of the Tumor Response to Neoadjuvant Chemotherapy in Women With Locoregional Invasive Breast Cancer Using Tc99m Sestamibi Molecular Breast Imaging: A Prospective Study",
"has_exemption": false,
"start_date": "2015-06-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02710968",
"publication_url": "https://clinicaltrials.gov/study/NCT02710968",
"title": "Study of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2015-08-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02629809",
"publication_url": "https://clinicaltrials.gov/study/NCT02629809",
"title": "First-Line Therapy With Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA-101) (iFCG) for Patients With Chronic Lymphocytic Leukemia (CLL) With Mutated IGHV Gene and Non-Del(17p)",
"has_exemption": false,
"start_date": "2016-03-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02742883",
"publication_url": "https://clinicaltrials.gov/study/NCT02742883",
"title": "A Phase 2 Study of Atengenal (A-10) and Astugenal (AS2-1) in Diffuse, Intrinsic Pontine Glioma (DIPG)",
"has_exemption": false,
"start_date": "2016-04-13",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Burzynski Research Institute",
"sponsor_slug": "burzynski-research-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02703623",
"publication_url": "https://clinicaltrials.gov/study/NCT02703623",
"title": "A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2016-05-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03011684",
"publication_url": "https://clinicaltrials.gov/study/NCT03011684",
"title": "Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial",
"has_exemption": false,
"start_date": "2016-07-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02724579",
"publication_url": "https://clinicaltrials.gov/study/NCT02724579",
"title": "A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients",
"has_exemption": false,
"start_date": "2017-11-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03682289",
"publication_url": "https://clinicaltrials.gov/study/NCT03682289",
"title": "Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2019-01-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03865290",
"publication_url": "https://clinicaltrials.gov/study/NCT03865290",
"title": "Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia",
"has_exemption": false,
"start_date": "2019-04-02",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998254",
"publication_url": "https://clinicaltrials.gov/study/NCT03998254",
"title": "A Phase 3 Randomized, Double-Blinded, Controlled With GARDASIL® Efficacy, Immunogenicity and Safety Study of V503 [a 9-Valent HPV Vaccine] in Chinese Women 20 to 45 Years of Age",
"has_exemption": false,
"start_date": "2019-06-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04099056",
"publication_url": "https://clinicaltrials.gov/study/NCT04099056",
"title": "Brain Stimulation Studies of Decision-making Using Repetitive Transcranial Magnetic Stimulation (rTMS) and Temporal Interference (TI)",
"has_exemption": false,
"start_date": "2019-11-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04261712",
"publication_url": "https://clinicaltrials.gov/study/NCT04261712",
"title": "An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)",
"has_exemption": false,
"start_date": "2020-01-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04248452",
"publication_url": "https://clinicaltrials.gov/study/NCT04248452",
"title": "A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)",
"has_exemption": false,
"start_date": "2020-05-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04560803",
"publication_url": "https://clinicaltrials.gov/study/NCT04560803",
"title": "Using Autologous Epidermal Skin Micrografts to Improve Healing In Radiation Wounds: A Pilot Study",
"has_exemption": false,
"start_date": "2021-01-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04230356",
"publication_url": "https://clinicaltrials.gov/study/NCT04230356",
"title": "A Randomized Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells (VSTs) for Control of Viral Infections After Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2021-01-27",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408638",
"publication_url": "https://clinicaltrials.gov/study/NCT04408638",
"title": "A Phase III, Open-Label, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Glofitamab in Combination With Gemcitabine Plus Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2021-02-23",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04696029",
"publication_url": "https://clinicaltrials.gov/study/NCT04696029",
"title": "Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04848506",
"publication_url": "https://clinicaltrials.gov/study/NCT04848506",
"title": "A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment With Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04486833",
"publication_url": "https://clinicaltrials.gov/study/NCT04486833",
"title": "A Phase 1/2 Open-Label, Dose-Escalation and Clinical Response Study of Quaratusugene Ozeplasmid in Combination With Osimertinib in Patients With Advanced, Metastatic EGFR-Mutant, Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2021-09-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genprex, Inc.",
"sponsor_slug": "genprex-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05150704",
"publication_url": "https://clinicaltrials.gov/study/NCT05150704",
"title": "Single Blind Randomized Controlled Trial to Assess the Safety and Efficacy of High Dose Pulse Intravenous Corticosteroid Therapy to Treat Patients With Complicated/Fulminant Acute Myocarditis",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Niguarda Hospital",
"sponsor_slug": "niguarda-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04982419",
"publication_url": "https://clinicaltrials.gov/study/NCT04982419",
"title": "Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04840602",
"publication_url": "https://clinicaltrials.gov/study/NCT04840602",
"title": "A Phase II Randomized Study Comparing BTK Inhibitors (Ibrutinib Plus Rituximab or Zanubrutinib Alone) vs. BCL-2 Inhibitor (Venetoclax) and Rituximab in Previously Untreated Waldenström's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL)",
"has_exemption": false,
"start_date": "2022-01-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04879043",
"publication_url": "https://clinicaltrials.gov/study/NCT04879043",
"title": "A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients With Plasma Cell Disorders Including Multiple Myeloma",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Heidelberg Pharma AG",
"sponsor_slug": "heidelberg-pharma-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04977180",
"publication_url": "https://clinicaltrials.gov/study/NCT04977180",
"title": "Phase II Trial of Cardioprotective Prophylaxis With Combination of Beta Blocker and Angiotensin-Converting Enzyme Inhibitors During Intensive Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2022-03-04",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269381",
"publication_url": "https://clinicaltrials.gov/study/NCT05269381",
"title": "A Phase I/II Study of Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab in Advanced Solid Tumors (PNeoVCA)",
"has_exemption": false,
"start_date": "2022-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05376267",
"publication_url": "https://clinicaltrials.gov/study/NCT05376267",
"title": "Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)",
"has_exemption": false,
"start_date": "2022-08-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05523947",
"publication_url": "https://clinicaltrials.gov/study/NCT05523947",
"title": "A Phase 1/2, Open-label, Multicenter, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of YH32367 in Patients With HER2-Positive Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2022-08-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yuhan Corporation",
"sponsor_slug": "yuhan-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05504291",
"publication_url": "https://clinicaltrials.gov/study/NCT05504291",
"title": "Intravitreal Melphalan for Intraocular Retinoblastoma",
"has_exemption": false,
"start_date": "2022-11-04",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05581303",
"publication_url": "https://clinicaltrials.gov/study/NCT05581303",
"title": "A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)",
"has_exemption": false,
"start_date": "2022-12-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05549297",
"publication_url": "https://clinicaltrials.gov/study/NCT05549297",
"title": "Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination With Pembrolizumab Versus Investigator's Choice in HLA-A*02:01-positive Participants With Previously Treated Advanced Melanoma (TEBE-AM)",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunocore Ltd",
"sponsor_slug": "immunocore-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05723198",
"publication_url": "https://clinicaltrials.gov/study/NCT05723198",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata",
"has_exemption": false,
"start_date": "2023-02-27",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05711394",
"publication_url": "https://clinicaltrials.gov/study/NCT05711394",
"title": "A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6-17 Years of Age.",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764720",
"publication_url": "https://clinicaltrials.gov/study/NCT05764720",
"title": "A Prospective Trial of Stereotactic Adaptive Radiation Therapy for Borderline Resectable/Locally Advanced Pancreatic Cancer: An Individualized Approach to Minimizing Gastrointestinal Toxicity (ARTIA-Pancreas)",
"has_exemption": false,
"start_date": "2023-05-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05889182",
"publication_url": "https://clinicaltrials.gov/study/NCT05889182",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05871372",
"publication_url": "https://clinicaltrials.gov/study/NCT05871372",
"title": "Intracranial Investigation of Neural Circuity Underlying Human Mood",
"has_exemption": false,
"start_date": "2023-07-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796440",
"publication_url": "https://clinicaltrials.gov/study/NCT05796440",
"title": "An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06019949",
"publication_url": "https://clinicaltrials.gov/study/NCT06019949",
"title": "Neuromodulatory Rehabilitation for Respiratory Motor Function in Individuals With Chronic Spinal Cord Injury",
"has_exemption": false,
"start_date": "2023-09-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05848713",
"publication_url": "https://clinicaltrials.gov/study/NCT05848713",
"title": "AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Manitoba",
"sponsor_slug": "university-of-manitoba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06149403",
"publication_url": "https://clinicaltrials.gov/study/NCT06149403",
"title": "A Multi-center, Randomized, Active Controlled Clinical Trial to Evaluate the Efficacy and Safety of OTL-203 in Subjects With Mucopolysaccharidosis Type I, Hurler Syndrome (MPS-IH) Compared to Standard of Care With Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orchard Therapeutics",
"sponsor_slug": "orchard-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118411",
"publication_url": "https://clinicaltrials.gov/study/NCT06118411",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects With Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109467",
"publication_url": "https://clinicaltrials.gov/study/NCT06109467",
"title": "A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06225596",
"publication_url": "https://clinicaltrials.gov/study/NCT06225596",
"title": "A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)",
"has_exemption": false,
"start_date": "2024-01-24",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100641",
"publication_url": "https://clinicaltrials.gov/study/NCT05100641",
"title": "Randomized Phase 3 Trial of Standard Care Plus AV-GBM-1 vs Autologous Monocytes as Adjunctive Therapy Following Primary Surgery Plus Concurrent Radiation-temozolomide in Patients With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aivita Biomedical, Inc.",
"sponsor_slug": "aivita-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06108934",
"publication_url": "https://clinicaltrials.gov/study/NCT06108934",
"title": "A Prospective, Pre-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia Hip Stem in Total Hip Arthroplasty (THA)",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Australia Pty Ltd.",
"sponsor_slug": "stryker-australia-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06223867",
"publication_url": "https://clinicaltrials.gov/study/NCT06223867",
"title": "Evaluation of Efficacy, Effectiveness, and Implementation of Jaspr Health's Digital Platform in Emergency Department for Patients With Suicidal Risk- Part A: Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-23",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05692024",
"publication_url": "https://clinicaltrials.gov/study/NCT05692024",
"title": "COMMENCER: COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER",
"has_exemption": false,
"start_date": "2024-03-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06309264",
"publication_url": "https://clinicaltrials.gov/study/NCT06309264",
"title": "Benefits of Speech-based Audiometry and Low-gain Hearing Aids for Blast-exposed Veterans",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05823532",
"publication_url": "https://clinicaltrials.gov/study/NCT05823532",
"title": "Targeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients With Schizophrenia Using an Anti-Inflammatory Challenge.",
"has_exemption": false,
"start_date": "2024-04-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861986",
"publication_url": "https://clinicaltrials.gov/study/NCT05861986",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Patients With Spinal Muscular Atrophy After Gene Therapy",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483334",
"publication_url": "https://clinicaltrials.gov/study/NCT06483334",
"title": "A Phase 1/2 Randomized, Umbrella Study to Evaluate the Efficacy and Safety of MK-2870 Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab, as Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04C",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107062",
"publication_url": "https://clinicaltrials.gov/study/NCT06107062",
"title": "Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial",
"has_exemption": false,
"start_date": "2024-07-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428019",
"publication_url": "https://clinicaltrials.gov/study/NCT06428019",
"title": "A Prospective, Open-Label, Phase IIb/III Study to Evaluate the Risk of TLS and Optimization of the Initiation of Venetoclax in Combination With Obinutuzumab or Acalabrutinib With Different Ramp- Up Periods in Previously Untreated Subjects With CLL",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06442566",
"publication_url": "https://clinicaltrials.gov/study/NCT06442566",
"title": "Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)",
"has_exemption": false,
"start_date": "2024-08-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508658",
"publication_url": "https://clinicaltrials.gov/study/NCT06508658",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared to Rituximab Plus Gemcitabine and Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861999",
"publication_url": "https://clinicaltrials.gov/study/NCT05861999",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06096116",
"publication_url": "https://clinicaltrials.gov/study/NCT06096116",
"title": "Phase 3, Double-blind, Placebo-controlled, Multicentre Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass",
"has_exemption": false,
"start_date": "2024-08-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Octapharma",
"sponsor_slug": "octapharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667701",
"publication_url": "https://clinicaltrials.gov/study/NCT05667701",
"title": "Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajesh Kumar",
"sponsor_slug": "rajesh-kumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06053814",
"publication_url": "https://clinicaltrials.gov/study/NCT06053814",
"title": "A Phase 1/2, First in Human, Multiple-dose, 2-part Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NS-050/NCNP-03 in Boys With Duchenne Muscular Dystrophy (DMD)",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184750",
"publication_url": "https://clinicaltrials.gov/study/NCT06184750",
"title": "Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction (RENAISSANCE): A Phase II Single Arm Trial",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679270",
"publication_url": "https://clinicaltrials.gov/study/NCT06679270",
"title": "An Open-label Extension of APG-20 Study to Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chiesi Farmaceutici S.p.A.",
"sponsor_slug": "chiesi-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04530058",
"publication_url": "https://clinicaltrials.gov/study/NCT04530058",
"title": "The Effects of Metformin on Morbidity and Mortality in Elderly Patients- a Prospective Randomized Control Trial (RCT)",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679946",
"publication_url": "https://clinicaltrials.gov/study/NCT06679946",
"title": "An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06381154",
"publication_url": "https://clinicaltrials.gov/study/NCT06381154",
"title": "MC230404 Photodynamic Priming to Facilitate Immunologic Activity of Anti-PD1 in Patients With Pancreatic Cancer",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06282809",
"publication_url": "https://clinicaltrials.gov/study/NCT06282809",
"title": "The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "HistoSonics, Inc.",
"sponsor_slug": "histosonics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05427695",
"publication_url": "https://clinicaltrials.gov/study/NCT05427695",
"title": "Topical Probiotic Sinus Irrigations for the Treatment of Chronic Rhinosinusitis: a Double Blinded Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855212",
"publication_url": "https://clinicaltrials.gov/study/NCT06855212",
"title": "A Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06830044",
"publication_url": "https://clinicaltrials.gov/study/NCT06830044",
"title": "A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06689085",
"publication_url": "https://clinicaltrials.gov/study/NCT06689085",
"title": "Open-Label, Multiple-Dose, 52-Week Study + 24-Month Long-Term Safety Extension to Evaluate the Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Deficiency or Absence of Endogenous Testosterone Due to Primary or Secondary Hypogonadism",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Halozyme Therapeutics",
"sponsor_slug": "halozyme-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311214",
"publication_url": "https://clinicaltrials.gov/study/NCT06311214",
"title": "Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06812832",
"publication_url": "https://clinicaltrials.gov/study/NCT06812832",
"title": "Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Madigan Army Medical Center",
"sponsor_slug": "madigan-army-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820463",
"publication_url": "https://clinicaltrials.gov/study/NCT06820463",
"title": "A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06414460",
"publication_url": "https://clinicaltrials.gov/study/NCT06414460",
"title": "A Phase 1/2, Open-Label, Multicenter, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Preliminary Efficacy of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "InSilico Medicine Hong Kong Limited",
"sponsor_slug": "insilico-medicine-hong-kong-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06579196",
"publication_url": "https://clinicaltrials.gov/study/NCT06579196",
"title": "Evaluation of Trabedersen (OT-101) With Pembrolizumab in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer and Positive PD-L1",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702553",
"publication_url": "https://clinicaltrials.gov/study/NCT06702553",
"title": "Effect of Inhaled Nitric Oxide on Major Adverse Events Requiring Intensive Life Support in Adults Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Phase III, Double-Blind, Multicenter, Randomized Controlled Trial (Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass, the NORISC Trial)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xijing Hospital",
"sponsor_slug": "xijing-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06485843",
"publication_url": "https://clinicaltrials.gov/study/NCT06485843",
"title": "An Open Label Phase IIb Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ageless Biotech, Inc.",
"sponsor_slug": "ageless-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06340568",
"publication_url": "https://clinicaltrials.gov/study/NCT06340568",
"title": "A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075718",
"publication_url": "https://clinicaltrials.gov/study/NCT07075718",
"title": "Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Glaukos Corporation",
"sponsor_slug": "glaukos-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951594",
"publication_url": "https://clinicaltrials.gov/study/NCT06951594",
"title": "Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045909",
"publication_url": "https://clinicaltrials.gov/study/NCT07045909",
"title": "A Phase 2, Open-label, Multicenter Multi-cohort Study to Evaluate the Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06356155",
"publication_url": "https://clinicaltrials.gov/study/NCT06356155",
"title": "A Phase II, Open-label, Single-arm, Multi-center Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer (NEPTUNE)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06850805",
"publication_url": "https://clinicaltrials.gov/study/NCT06850805",
"title": "A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Optinose US Inc.",
"sponsor_slug": "optinose-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070232",
"publication_url": "https://clinicaltrials.gov/study/NCT07070232",
"title": "A Phase I/II, Open-label, Adaptive Two-part Trial to Evaluate the Safety, Efficacy, Optimal Dose and Pharmacokinetics of BNT326 as Monotherapy and in Combination With Cancer Immunotherapies in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959524",
"publication_url": "https://clinicaltrials.gov/study/NCT06959524",
"title": "AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114380",
"publication_url": "https://clinicaltrials.gov/study/NCT07114380",
"title": "Investigation of Cold Snare Polypectomy for Removing 10-20 mm 0-Ip Colorectal Polyp: One Feasibility and Safety Study",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Taiwan University Hospital",
"sponsor_slug": "national-taiwan-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023835",
"publication_url": "https://clinicaltrials.gov/study/NCT07023835",
"title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202884",
"publication_url": "https://clinicaltrials.gov/study/NCT07202884",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07181837",
"publication_url": "https://clinicaltrials.gov/study/NCT07181837",
"title": "A Multi-Center, Open-label, Phase 1/2 Trial of the Safety and Efficacy of MVX-220 Gene Therapy Administered by Intra-Cisterna Magna Injection to Participants With Angelman Syndrome",
"has_exemption": false,
"start_date": "2025-10-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MavriX Bio, LLC",
"sponsor_slug": "mavrix-bio-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699121",
"publication_url": "https://clinicaltrials.gov/study/NCT06699121",
"title": "A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "LISCure Biosciences",
"sponsor_slug": "liscure-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205601",
"publication_url": "https://clinicaltrials.gov/study/NCT07205601",
"title": "Phase 2a Assessment of Safety, Tolerability, and Efficacy of Repeated Dosing of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneration Biomedical, Inc.",
"sponsor_slug": "regeneration-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06917313",
"publication_url": "https://clinicaltrials.gov/study/NCT06917313",
"title": "A Randomized Phase II Study to Evaluate the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219602",
"publication_url": "https://clinicaltrials.gov/study/NCT07219602",
"title": "A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome (RUBENS Trial)",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NewAmsterdam Pharma",
"sponsor_slug": "newamsterdam-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722183",
"publication_url": "https://clinicaltrials.gov/study/NCT06722183",
"title": "FUTURE Platform Trial - A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest",
"sponsor_slug": "institut-fur-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225712",
"publication_url": "https://clinicaltrials.gov/study/NCT07225712",
"title": "A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Tolerability, Safety, and Efficacy of Long-term Administration of SEP-363856 in Patients With Schizophrenia",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Co., Ltd.",
"sponsor_slug": "otsuka-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284979",
"publication_url": "https://clinicaltrials.gov/study/NCT07284979",
"title": "A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07398417",
"publication_url": "https://clinicaltrials.gov/study/NCT07398417",
"title": "A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia",
"has_exemption": false,
"start_date": "2026-01-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Axsome Therapeutics, Inc.",
"sponsor_slug": "axsome-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183319",
"publication_url": "https://clinicaltrials.gov/study/NCT07183319",
"title": "Circulating Tumor DNA Response Adapted Treatment De-escalation Metastatic Urothelial Carcinoma (CT-READ)",
"has_exemption": false,
"start_date": "2026-01-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258407",
"publication_url": "https://clinicaltrials.gov/study/NCT07258407",
"title": "A Phase 1/2 Dose Escalation Trial With Administration Schedule Exploration Evaluating Single Agent TD001, a PSMA-Targeted Antibody-Drug Conjugate, in Patients With PSMA-Expressing Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "T.O.A.D. Oncology SA",
"sponsor_slug": "toad-oncology-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04901741",
"publication_url": "https://clinicaltrials.gov/study/NCT04901741",
"title": "An Open-label Phase 2 Study of Olaptesed Pegol (NOX-A12) Combined With Pembrolizumab and Nanoliposomal Irinotecan/5-FU/Leucovorin or Gemcitabine/Nab-paclitaxel in Microsatellite-stable Metastatic Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TME Pharma AG",
"sponsor_slug": "tme-pharma-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322003",
"publication_url": "https://clinicaltrials.gov/study/NCT07322003",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prilenia",
"sponsor_slug": "prilenia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321886",
"publication_url": "https://clinicaltrials.gov/study/NCT07321886",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-02-06",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07353931",
"publication_url": "https://clinicaltrials.gov/study/NCT07353931",
"title": "A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Osteoarthritis Knee Pain, and Obesity or Overweight (ENLIGHTEN-4)",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369011",
"publication_url": "https://clinicaltrials.gov/study/NCT07369011",
"title": "A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Moderate to Severe Obstructive Sleep Apnea, and Obesity or Overweight",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07420283",
"publication_url": "https://clinicaltrials.gov/study/NCT07420283",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study With a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine With or Without Naloxone in Early Recovery of Participants With Opioid Use Disorder (RENEW-Op-1)",
"has_exemption": false,
"start_date": "2026-02-13",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842498",
"publication_url": "https://clinicaltrials.gov/study/NCT06842498",
"title": "A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-02-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyntra Bio",
"sponsor_slug": "kyntra-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287150",
"publication_url": "https://clinicaltrials.gov/study/NCT07287150",
"title": "A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of the Combination of Inavolisib Plus Enzalutamide Versus Physician's Choice of ARPI or Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07477457",
"publication_url": "https://clinicaltrials.gov/study/NCT07477457",
"title": "OstEvo - Osteosarcoma Evolves",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07542470",
"publication_url": "https://clinicaltrials.gov/study/NCT07542470",
"title": "Assessing Outcomes in Spinal Surgery Patients Who Receive Iceless Cryopneumatic Therapy Using the NICE1 Device as Compared to Standard of Care",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarasota Memorial Health Care System",
"sponsor_slug": "sarasota-memorial-health-care-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339358",
"publication_url": "https://clinicaltrials.gov/study/NCT07339358",
"title": "Safety & Performance of the World Medica World Diverter Embolization Device",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "World Medica USA, LLC",
"sponsor_slug": "world-medica-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07401290",
"publication_url": "https://clinicaltrials.gov/study/NCT07401290",
"title": "The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vance Thompson Vision",
"sponsor_slug": "vance-thompson-vision",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07389031",
"publication_url": "https://clinicaltrials.gov/study/NCT07389031",
"title": "Maralixibat for the trEatment of inTrAhePatic cHOlestasis of pRegnancy (METAPHOR)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Imperial College London",
"sponsor_slug": "imperial-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07432659",
"publication_url": "https://clinicaltrials.gov/study/NCT07432659",
"title": "Add-On Efficacy of Home-Based Transcutaneous Tibial Nerve Stimulation Via the ZIDA Control Sock in Adults With Overactive Bladder on Preexisting Stable Pharmacotherapy",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07414745",
"publication_url": "https://clinicaltrials.gov/study/NCT07414745",
"title": "MDT-0123 Clinical Trial Targeting Patients Who Require Lumbar Vertebral Fusion in Japan",
"has_exemption": false,
"start_date": "2026-04-24",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Spinal and Biologics",
"sponsor_slug": "medtronic-spinal-and-biologics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07536269",
"publication_url": "https://clinicaltrials.gov/study/NCT07536269",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Crinecerfont in Pediatric Participants 3 Months to <4 Years of Age With Classic Congenital Adrenal Hyperplasia",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07614321",
"publication_url": "https://clinicaltrials.gov/study/NCT07614321",
"title": "Is Silodosin Effective for Treating Lower Urinary Tract Symptoms in Female Patients With Multiple Sclerosis? A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Atlantic Health System",
"sponsor_slug": "atlantic-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07602699",
"publication_url": "https://clinicaltrials.gov/study/NCT07602699",
"title": "A Multi-Site Trial of Tirzepatide for Smoking Cessation",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07568145",
"publication_url": "https://clinicaltrials.gov/study/NCT07568145",
"title": "PREVENT Study: Promoting Resilience Via Early Neurostimulation After Trauma",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07585968",
"publication_url": "https://clinicaltrials.gov/study/NCT07585968",
"title": "Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiac Ablation Solutions",
"sponsor_slug": "medtronic-cardiac-ablation-solutions",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07663422",
"publication_url": "https://clinicaltrials.gov/study/NCT07663422",
"title": "GU-228: Mycophenolate Mofetil in Combination With Prednisone as First-line Treatment of Immune Related Hepatitis Resulting From Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06137365",
"publication_url": "https://clinicaltrials.gov/study/NCT06137365",
"title": "A Randomized, Placebo-Controlled Clinical Trial of Once Daily Oral Cannabis for Weight Loss in Obese Individuals",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Joshua A. Lile, Ph.D.",
"sponsor_slug": "joshua-a-lile-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06605651",
"publication_url": "https://clinicaltrials.gov/study/NCT06605651",
"title": "A Phase II Proof of Concept Multicenter, Randomized, Double-Blind Study to Assess the Safety and Efficacy of Phage Therapy in Patients With Hip or Knee Prosthetic Joint Infection Due to Staphylococcus Aureus Treated by DAIR",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Phagenix",
"sponsor_slug": "phagenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07414992",
"publication_url": "https://clinicaltrials.gov/study/NCT07414992",
"title": "Neoadjuvant STereotActic Body Radiotherapy and Cemiplimab With or Without Fianlimab for Cisplatin-Ineligible or Cisplatin-Declining Patients With Muscle-Invasive Bladder Cancer (NeoSTAR Bladder)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431307",
"publication_url": "https://clinicaltrials.gov/study/NCT07431307",
"title": "A Two-part Phase IIb Randomized, Multicenter, Open-label Comparative Study to Firstly Evaluate the Safety and Efficacy Trial of BV100 in Combination With Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol Versus Best Available Therapy in Patients With Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia and Bloodstream Infection, Suspected or Confirmed to be Due to Carbapenem-resistant Acinetobacter Baumannii Calcoaceticus Complex (CRABC), and Secondly to Evaluate the Pharmacokinetics of BV100 in Combination With Low Dose Polymyxin B Plus Cefideroc",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioVersys AG",
"sponsor_slug": "bioversys-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07695558",
"publication_url": "https://clinicaltrials.gov/study/NCT07695558",
"title": "Post Market Study of the Flexagon Only System and Flexagon Plus OTOLoc for Creation of Side-to-Side Duodeno-Ileal Diversion & Flexagon Plus OTOLoc Self Forming Magnet (SFM) System for Creation of Side-to-Side Jejunum-Jejunum and Ileal-Ileal Anastomoses",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GI Windows, Inc.",
"sponsor_slug": "gi-windows-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07723248",
"publication_url": "https://clinicaltrials.gov/study/NCT07723248",
"title": "A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination With Darolutamide Compared With ARPI or Docetaxel in Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Abiraterone Acetate (Himalayas-1)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ORIC Pharmaceuticals",
"sponsor_slug": "oric-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07304102",
"publication_url": "https://clinicaltrials.gov/study/NCT07304102",
"title": "Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07465757",
"publication_url": "https://clinicaltrials.gov/study/NCT07465757",
"title": "A Phase 2 Study of Alisertib in Combination With Paclitaxel in Patients With Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Puma Biotechnology, Inc.",
"sponsor_slug": "puma-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06792500",
"publication_url": "https://clinicaltrials.gov/study/NCT06792500",
"title": "Investigational Study of Glycerol Tributyrate in MELAS and LHON-Plus",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}